Pharmaceutical products comprising bisphosphonates

Details Pharmaceutical products comprising bisphosphonates Pharmaceutical products comprising bisphosphonates

2011-04-26

2011-04-26

Henley, III, Raymond J (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

Reexamination Certificate

active

07932241

ABSTRACT:
A pharmaceutical product comprises a container containing a bisphosphonate solution, in which at least the internal surface of the container comprises a plastic material and in which the container is heat sterilisable, and which is in the form of a ready to use infusion solution, for administration of the bisphosphonate to a patient in need of bisphosphonate treatment.

REFERENCES:
patent: A-08-92102 (1996-04-01), None
patent: 02/22136 (2002-03-01), None
patent: 02/087592 (2002-11-01), None
patent: 02/089768 (2002-11-01), None
patent: WO 2005/025551 (2005-03-01), None
Nakamura et al., “Failure of Stability Prediction for Minodronic Acid Injectable by Accelerated Stability Testing”, International Journal of Pharmaceutics, vol. 241, No. 1, pp. 65-71 (2002).
Tchiakpe et al., “Stedim 6 and Clearflex, Two New Multilayer Materials for Infusion Containsers. Comparative Study of their Compatibility with Five Drugs Versus Glass Flasks and Polyvinyl Chloride Bags”, Journal of Biomaterials Science Polymer Edition, vol. 7, No. 3, pp. 199-206 (1995).
Okuda et al., “Stems used in drug names: for the better understanding of pharmacological actions of drugs”. Pharm. Tech. Japan, vol. 24, No. 13, (2008), pp. 2687-2693.

Affiliated with

Also associated with

Rating

Pharmaceutical products comprising bisphosphonates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical products comprising bisphosphonates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical products comprising bisphosphonates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2627027